Prostate Cancer, Version 1.2016

Restricted access

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naïve disease.

Provided content development and/or authorship assistance.

Supplementary Materials

    • Supplemental Material (PDF 211 KB)
All Time Past Year Past 30 Days
Abstract Views 1 1 0
Full Text Views 2061 2061 221
PDF Downloads 378 378 34
EPUB Downloads 0 0 0